| 0.1 |
0.2 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.0 |
0.2 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.0 |
0.1 |
GO:0060981 |
cell migration involved in coronary angiogenesis(GO:0060981) |
| 0.0 |
0.3 |
GO:0001554 |
luteolysis(GO:0001554) |
| 0.0 |
0.2 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.0 |
0.1 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.0 |
0.2 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.0 |
0.2 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.0 |
0.1 |
GO:1990654 |
sebum secreting cell proliferation(GO:1990654) |
| 0.0 |
0.1 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.0 |
0.1 |
GO:0002877 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
| 0.0 |
0.1 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.0 |
0.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.1 |
GO:1902823 |
negative regulation of late endosome to lysosome transport(GO:1902823) regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.0 |
0.1 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.0 |
0.2 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.0 |
0.2 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) myoblast fate commitment(GO:0048625) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.0 |
0.1 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.0 |
0.2 |
GO:0030336 |
negative regulation of cell migration(GO:0030336) negative regulation of cell motility(GO:2000146) |
| 0.0 |
0.0 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.0 |
0.1 |
GO:0034627 |
'de novo' NAD biosynthetic process(GO:0034627) |
| 0.0 |
0.1 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 |
0.0 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.0 |
0.1 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.0 |
0.1 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 |
0.1 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.0 |
0.0 |
GO:0035564 |
regulation of kidney size(GO:0035564) |
